Everything below concerns RP-HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; may appear as cake |
| Solubility class | Water-soluble | Often reconstituted in aqueous buffer |
| Typical storage temperature | −20 °C or below | Protect from light and moisture |
| Typical analytical method | RP-HPLC and mass spectrometry | Used for purity and identity |
| Common synonyms | AOD-9604; AOD9604; hGH fragment 176-191 | Research name and fragment description |
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
In the case of germline editing, there is no guarantee that treatment will provide an absolute cure throughout the patient's life and/or whether those genes can be passed onto their offspring. Although CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a technique that allows for genes to be edited with ease may present certain benefits, but it may also cause further risks to the human body. For example, there may be technical limitations to CRISPR editing. Until advancements are made to fully equip scientists with the knowledge to understand all potential benefits and risks associated with CRISPR editing, concerns regarding the safety of its applications remain. The possibility that editing could bring about an incomplete or inaccurate genetic sequence has been reported in several experiments related to both animal and human cell line studies. Since it is almost impossible to predict a favorable outcome with certainty, this technique makes germline editing all the more difficult to promote as a definite cure for anyone suffering from terminal illnesses.
Gross report to have evidenced and quantified DMT, along with its structural analog bufotenin (5-HO-DMT), in human blood and urine. In an article published four months later, the method used in their study was strongly criticized, and the credibility of their results challenged. Few of the analytical methods used prior to 2001 to measure levels of endogenously formed DMT had enough sensitivity and selectivity to produce reliable results. Gas chromatography, preferably coupled to mass spectrometry (GC-MS), is considered a minimum requirement. A study published in 2005 implements the most sensitive and selective method ever used to measure endogenous DMT: liquid chromatography-tandem mass spectrometry with electrospray ionization (LC-ESI-MS/MS) allows for reaching limits of detection (LODs) 12 to 200 fold lower than those attained by the best methods employed in the 1970s. The data summarized in the table below are from studies conforming to the abovementioned requirements (abbreviations used: CSF = cerebrospinal fluid; LOD = limit of detection; n = number of samples; ng/L and ng/kg = nanograms (10−9 g) per litre, and nanograms per kilogram, respectively):
In two tandem Letters to the Editor (1936), Wrinch and Frank addressed the question of whether the cyclol form of the peptide group was indeed more stable than the amide form. A relatively simple calculation showed that the cyclol form is significantly less stable than the amide form. Therefore, the cyclol model would have to be abandoned unless a compensating source of energy could be identified. Initially, Frank proposed that the cyclol form might be stabilized by better interactions with the surrounding solvent; later, Wrinch and Irving Langmuir hypothesized that hydrophobic association of nonpolar sidechains provides stabilizing energy to overcome the energetic cost of the cyclol reactions. The lability of the cyclol bond was seen as an advantage of the model, since it provided a natural explanation for the properties of denaturation; reversion of cyclol bonds to their more stable amide form would open up the structure and allows those bonds to be attacked by proteases, consistent with experiment. Early studies showed that proteins denatured by pressure are often in a different state than the same proteins denatured by high temperature, which was interpreted as possibly supporting the cyclol model of denaturation. The Langmuir-Wrinch hypothesis of hydrophobic stabilization shared in the downfall of the cyclol model, owing mainly to the influence of Linus Pauling, who favored the hypothesis that protein structure was stabilized by hydrogen bonds.
=== Kuwaiti resistance movement === Kuwaitis founded a local armed resistance movement following the Iraqi occupation of Kuwait. The Kuwaiti resistance's casualty rate far exceeded that of the coalition military forces and Western hostages. The resistance predominantly consisted of ordinary citizens who lacked any form of training and supervision.
=== Applications === The enhanced sensitivity of eSimoa is crucial for early and accurate biomarker detection in clinical diagnostics, facilitating better disease monitoring and management. In drug discovery, the ability to track subtle changes in enzymatic activity aids in the development of more effective pharmaceuticals by providing detailed insights into enzyme inhibition mechanisms.
Sources: en.wikipedia.org
They granted a worldwide sublicense of the technology to a small (less than $100M in sales), innovative company well known for its cutting-edge column technology: Phenomenex. This was a superior strategic move for two reasons. As mentioned above, Merck is not well known for its column manufacturing. Furthermore, having more than one silica monolith manufacturer serves to better validate the technology. Having sublicensed the technology from Merck, Phenomenex introduced its Onyx product line in January 2005. On the other side of monolith technologies are the polymerics. Unlike the inorganic silica columns, the polymer monoliths are made of an organic polymer base. Dionex, traditionally known for its ion chromatography capabilities, has led this side of the field. In the 1990s, Dionex first acquired a license for the polymeric monolith technology developed by leading monolithic chromatography researcher Frantisec Svec while he was at Cornell University. In 2000, they acquired LC Packings, whose competencies were in LC column packings. LC Packings/Dionex revealed their first monolithic capillary column at the Montreux LC-MS Conference. Earlier that year, another company, Isco, introduced a polystyrene divinylbenzene (PS-DVB) monolith column under the brand SWIFT. In January 2005, Dionex was sold the rights to Teledyne Isco's SWIFT media products, intellectual property, technology, and related assets.
Produced by Hilary Lawson, made by TVF Media 15 December Rheumatoid Arthritis, British scientists have discovered that sufferers lack a sugar in part of their immune system, namely the glycosylation of glycans on Immunoglobulin G (IgC); David Isenberg at Middlesex Hospital; the Pima tribe in Arizona, studied by British doctor Peter Bennett; the Hu Hu Kam Memorial Hospital in Sacaton, Arizona; Raymond Dwek researched glycobiology, how sugar molecules attached to the surface of cells; Tom Rademacher found that arthritis disappeared during pregnancy; Graham Rook, who researched microbiology at UCL, developed a biochemical test at Middlesex Hospital; people developed arthritis, in groups, across Lyme, Connecticut; Allen Steere of New England Medical Centre, who named Lyme disease.
== Related compounds == Other carbamates include methyl carbamate, butyl carbamate, and phenyl carbamate (m. p. 149–152 °C), which can also be prepared from the corresponding chloroformate and ammonia. These esters are white, crystalline solids at room temperature. Except for the phenyl carbamate, they sublime at moderate temperatures; methyl carbamate sublimes at room temperatures. The first two and ethyl carbamate are very soluble in water, benzene, and ether. These other carbamates (methyl, butyl, and phenyl) are only used in small quantities for research purposes.
=== Christianised forms === Most of the Grail romances do not differ much from Perceval. The two pieces that hold particularly stronger Christian themes than prior works are the influential Vulgate and Post-Vulgate versions of the Queste del Saint Graal (featured in Malory's compilation) and the Sone de Nausay. The Queste del Saint Graal is heavily Christian not only in terms of the tone but also the characters and significant objects. The Grail maidens become angels, there is a constant relationship between the knights and religious symbolism; most importantly, the Fisher King is replicated as a priest-like figure. In the case of Sone de Nausay, Bron (the Fisher King) is part of a tale in which the story makes a constant correlation between the Gospel narrative and the history of the Grail.
Sources: en.wikipedia.org
==== First two playoff appearances (1997–98) ==== The 1,000th hit of Bagwell's career was a home run on May 20, 1997, off Calvin Maduro, one of his two that game, in a 9–5 win over the Philadelphia Phillies. He was selected to the play in the All-Star Game. Exhibiting above-average speed and baserunning skills for a first baseman, Bagwell became the first full-time first baseman to join the 30–30 club, capping the 1997 season with 31 steals in 41 attempts. The only other first baseman to accomplish the 30–30 club is Joe Carter. Bagwell batted .286 and scored 109 runs. He finished second in the league with both 43 home runs and 135 RBI, his career high in RBI. He was third in the MVP balloting. He made the playoffs for the first time in 1997 when the Astros won the National League Central division, the club's first appearance in 11 years. The Astros faced the Atlanta Braves in the National League Division Series (NLDS), who swept them in three games. Bagwell, Biggio and Bell combined for two hits in 37 at bats. In 1998, Bagwell informed a Houston Chronicle reporter that he was using androstenedione (commonly referred to as "andro"), which at the time the United States Food and Drug Administration (FDA) classified it as a nutritional dietary supplement, finding it benign and authorized for non-medicinal purposes. It was considered a "weak" androgen steroid hormone and allegedly in widespread use around the sport at the time.[c] Bagwell hit his first career grand slam while tying a career-high six RBI against Cincinnati on September 8 in a 13–7 victory.
The United States House of Representatives passes a bill to curb university boycotts of Israel. OpenAI launches GPT-6, the next major version of ChatGPT. The National Fish and Wildlife Foundation announces $1.2 million in grants to reduce the extinction risk for Hawaiian forest birds and restore essential watershed habitats in Hawaii. September 4 The US military announces that it had disabled ad trackers on devices following reports that commercially available location data had been used to target its soldiers in the Middle East. The judge in the trial of Lindsay Clancy, a mother accused of murdering her three children, says he will declare a mistrial. The US Treasury announces that it has cut off Turkish investment bank Golden Global Yatirim Bankasi Anonim Sirketi and two subsidiaries from dollar transactions because of their dealings with the Iranian government. The price of diesel hits an all-time high of $5.85 per gallon, compared to an average of $3.71 a year ago and exceeding the previous high following Russia's full-scale invasion of Ukraine. September 5 The US military reports that it destroyed three IRGC-connected oil tankers in response to the latter's fire on its warships. Steve Witkoff and Jared Kushner meet Russian president Vladimir Putin in Moscow to deliver a proposal to end the war in Ukraine. In college football, ESPN College GameDay announces the inaugural "Hall of Fan" award, with the Ol’ Crimson flag from the Washington State Cougars as its first inductee.
Since uranium and plutonium are nuclear weapons materials, there are proliferation concerns. Ordinarily (in spent nuclear fuel), plutonium is reactor-grade plutonium. In addition to plutonium-239, which is highly suitable for building nuclear weapons, it contains large amounts of undesirable contaminants: plutonium-240, plutonium-241, and plutonium-238. These isotopes are extremely difficult to separate, and more cost-effective ways of obtaining fissile material exist (e.g., uranium enrichment or dedicated plutonium production reactors). High-level waste is full of highly radioactive fission products, most of which are relatively short-lived. This is a concern since if the waste is stored, perhaps in deep geological storage, over many years the fission products decay, decreasing the radioactivity of the waste and making the plutonium easier to access. The undesirable contaminant Pu-240 decays faster than the Pu-239, and thus the quality of the bomb material increases with time (although its quantity decreases during that time as well). Thus, some have argued, as time passes, these deep storage areas have the potential to become "plutonium mines", from which material for nuclear weapons can be acquired with relatively little difficulty. Critics of the latter idea have pointed out the difficulty of recovering useful material from sealed deep storage areas makes other methods preferable. Specifically, high radioactivity and heat (80 °C in surrounding rock) greatly increase the difficulty of mining a storage area, and the enrichment methods required have high capital costs.
Sources: en.wikipedia.org
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.
Reversed-phase HPLC and mass spectrometry are standard checks. They confirm peptide purity and molecular mass, but they do not by themselves demonstrate biological activity.
Synthesis, purification, and handling conditions can differ, leading to variations in purity and salt content. Certificates of analysis help, but independent testing is often needed for verification.
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.